Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 23, 2023
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
Tue, August 22, 2023
[ Tue, Aug 22nd 2023
] - WOPRAI
[ Tue, Aug 22nd 2023
] - WOPRAI
[ Tue, Aug 22nd 2023
] - WOPRAI
Charles Duncan Reiterated (BIVI) at Buy and Held Target at $110 on, Aug 22nd, 2023
Charles Duncan of Cantor Fitzgerald, Reiterated "BioVie Inc." (BIVI) at Buy and Held Target at $110 on, Aug 22nd, 2023.
Charles has made no other calls on BIVI in the last 4 months.
There is 1 other peer that has a rating on BIVI. Out of the 1 peers that are also analyzing BIVI, 0 agree with Charles's Rating of Hold.
This is the rating of the analyst that currently disagrees with Charles
- Jay Olson of "Oppenheimer" Reiterated at Buy and Held Target at $120 on, Wednesday, May 17th, 2023
